109 related articles for article (PubMed ID: 11920207)
1. Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemia.
Leotard S; Chastang C; Travade P; Jaudon MC; Tournilhac O; Baudet S; Merle-Beral H
Hematol J; 2000; 1(5):301-6. PubMed ID: 11920207
[TBL] [Abstract][Full Text] [Related]
2. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.
Sarfati M; Chevret S; Chastang C; Biron G; Stryckmans P; Delespesse G; Binet JL; Merle-Beral H; Bron D
Blood; 1996 Dec; 88(11):4259-64. PubMed ID: 8943862
[TBL] [Abstract][Full Text] [Related]
3. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
[TBL] [Abstract][Full Text] [Related]
4. Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta2-microglobulin in B-cell chronic lymphocytic leukemia.
Molica S; Levato D; Cascavilla N; Levato L; Musto P
Eur J Haematol; 1999 Feb; 62(2):117-22. PubMed ID: 10052715
[TBL] [Abstract][Full Text] [Related]
5. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia.
Knauf WU; Langenmayer I; Ehlers B; Mohr B; Adorf D; Nerl CH; Hallek M; Zwingers TH; Emmerich B; Thiel E
Leuk Lymphoma; 1997 Nov; 27(5-6):523-32. PubMed ID: 9477135
[TBL] [Abstract][Full Text] [Related]
8. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic significance of lactate dehydrogenase and beta2-microglobulin in chronic lymphocytic leukemia].
Shen QD; Xu W; Yu H; Li L; Zhang SJ; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1305-8. PubMed ID: 18088490
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic leukemia and prognostic factors.
Mozaheb Z; Hasanzadeh NazarAbadi MH; Aghaee MA
Asian Pac J Cancer Prev; 2012; 13(7):3009-13. PubMed ID: 22994703
[TBL] [Abstract][Full Text] [Related]
12. [Evolution of chronic lymphocytic leukemia: predictive value of immunophenotype, soluble CD23 and morphology].
Sarmientó MA; Palacios MF; Scolnik MP; Ramírez FR; Stanganelli C; Cabrera J; Chena CP; Arrossagaray G; Slavutsky IR; Bengió RM
Medicina (B Aires); 2002; 62(4):305-12. PubMed ID: 12325485
[TBL] [Abstract][Full Text] [Related]
13. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
Molica S; Levato D; Dell'Olio M; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
Haematologica; 1996; 81(5):428-33. PubMed ID: 8952156
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Gandolfo GM
Cancer; 2001 Aug; 92(4):713-9. PubMed ID: 11550139
[TBL] [Abstract][Full Text] [Related]
16. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.
Molica S; Vitelli G; Levato D; Levato L; Dattilo A; Gandolfo GM
Haematologica; 1999 Mar; 84(3):208-11. PubMed ID: 10189383
[TBL] [Abstract][Full Text] [Related]
17. The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experience.
Molica S; Mauro FR; Callea V; Giannarelli D; Lauria F; Rotoli B; Cortelezzi A; Liso V; Foà R
Haematologica; 2010 Mar; 95(3):464-9. PubMed ID: 19903673
[TBL] [Abstract][Full Text] [Related]
18. Early chronic lymphocytic leukemia: prognostic value of quantitative bone marrow MR imaging findings and correlation with hematologic variables.
Lecouvet FE; Vande Berg BC; Michaux L; Schmitz PJ; Malghem J; Jamart J; Maldague BE; Ferrant A; Michaux JL
Radiology; 1997 Sep; 204(3):813-8. PubMed ID: 9280265
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers.
Christiansen I; Gidlöf C; Wallgren AC; Simonsson B; Tötterman TH
Blood; 1994 Nov; 84(9):3010-6. PubMed ID: 7949173
[TBL] [Abstract][Full Text] [Related]
20. Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.
Piñeyroa JA; Magnano L; Rivero A; Rivas-Delgado A; Nadeu F; Correa JG; Giné E; Villamor N; Filella X; Colomer D; López M; López-Oreja I; Costa D; Aymerich M; Beà S; López-Guillermo A; Campo E; Delgado J; Mozas P
Hematol Oncol; 2022 Oct; 40(4):588-595. PubMed ID: 35611996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
